OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020

OptumRx, the pharmacy benefit unit of UnitedHealth Group, released a list of the three drugs it expects to have the biggest impact on payers and patients in 2020.

Optum said it expects the emphasis on orphan drugs to continue this year and to make up nearly 40 percent of newly approved drugs across all disease categories.